Ebola trial begins in DR Congo

What's happened

Health authorities have reported at least 1,759 confirmed Ebola cases and about 600 deaths in the Democratic Republic of Congo since mid-May, driven by the rare Bundibugyo strain. The World Health Organization has enrolled the first patient in a trial testing MBP134 and remdesivir; treatment centres are strained and insecurity and funding shortfalls are hindering response.

What's behind the headline?

What the trial changes

• The WHO has moved treatment testing into the outbreak: enrolling patients in an adaptive trial testing MBP134 and remdesivir will produce randomized evidence about therapies for Bundibugyo while the epidemic continues. The trial will track 28-day survival and can expand if necessary.

Why this will matter

• If one or both drugs improve survival, treatment centres will be able to offer an effective option and survival will increase. That will reduce community fear and lower deaths occurring outside care, which currently account for a large share of fatalities.

What is blocking success

• Contact tracing is incomplete and testing capacity is uneven, which will slow enrolment and case isolation. Security constraints and attacks on health facilities are preventing access to hot spots. Funding gaps have left response plans under-resourced.

Likely trajectory

• The trial will take months and may need hundreds to a thousand participants to show clear benefit. If the outbreak grows faster than enrolment, the trial will widen geographically; if enrolment is slow, results will lag and emergency use decisions will depend on interim signals.

Consequences beyond the DRC

• Rapid trial results will shape global guidance on Bundibugyo care and determine whether donated stockpiles or production scales up. Continued international funding shortfalls will worsen response capacity and increase the risk of wider spread.

How we got here

Officials have declared the DRCs 17th Ebola outbreak after weeks of undetected transmission in Ituri province. Bundibugyo is rare and has no approved vaccine or specific treatment. The WHO and partners have launched a clinical trial and scaled diagnostics and tracing amid conflict, community mistrust and stretched health services.

Our analysis

The WHO and Congolese health authorities have provided the core data: France 24 reported WHO figures of 1,759 confirmed cases and 600 deaths and quoted WHO representative Anne Ancia saying "the outbreak continues to expand, and its true scale has not yet been fully established." All Africa published an interview with Africa CDC director-general Jean Kaseya warning that transmission likely began before official detection and stressing the need to scale up response funding; Kaseya said late detection "costs lives". AP News, the Independent and the Associated Press coverage reproduced WHO statements that the trial will randomize patients to remdesivir, MBP134, both or neither and will track survival for 28 days; AP quoted WHO adviser Vasee Moorthy explaining the enrolment and timeline. Al Jazeera and France 24 highlighted operational challenges: treatment centres are near capacity, health workers face unpaid allowances and strikes were threatened, and insecurity and community mistrust are hampering access. Reuters, via the Independent and All Africa, noted a suspected case in Kisangani linked to Nia-Nia and another without a known connection, which authorities are investigating. Bloomberg, CNBC and the Japan Times underlined that the trial is WHO-sponsored and adaptive, testing MBP134 and remdesivir alongside supportive care in Ituri province. Together the sources show a consistent picture: a growing outbreak driven by Bundibugyo, an urgent but logistically difficult therapeutic trial, and persistent gaps in funding, security and community trust that will determine how quickly the epidemic is contained.

Go deeper

• How quickly will the trial expand beyond Bunia to other treatment centers?
• What steps are being taken to improve contact tracing and laboratory turnaround?
• How much of the Africa CDCs $518m plan has been funded and what happens if funding remains short?

More on these topics

• World Health Organization

  The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency's governing structure and principles, states its main objective as "the attainment

• Ituri Province - Province of DR Congo

  Ituri Province (French: Province de l'Ituri; Swahili: Mkoa wa Ituri) is one of the 26 provinces of the Democratic Republic of the Congo created in the 2015 repartitioning. Ituri, Bas-Uele, Haut-Uele, and Tshopo provinces are the result of the subdividing of the former Orientale province. Ituri was formed from the Ituri district, whose town of Bunia was elevated to capital city of the new province.

• Democratic Republic of the Congo - Country in Central Africa

  The Democratic Republic of the Congo, also known as Congo-Kinshasa, Zaire, DR Congo, DRC, the DROC, or simply the Congo, is a country located in Central Africa. It was formerly called Zaire.

• Remdesivir - Medication

  Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein.

• Kinshasa - Capital and the largest city of the Democratic Republic of the Congo having the status of a province

  Kinshasa (; French: [kinʃasa]; Lingala: Kinsásá), formerly named Léopoldville (Dutch: Leopoldstad) from 1881 to 1966, is the capital and largest city of the Democratic Republic of the Congo. Kinshasa is one of the world's fastest-growing megacities, with an estimated population of 18.5 million in 2026. It is the most densely populated city in the DRC, the third-most populous city and third-largest metropolitan area in Africa, the world's seventh-most populous city proper (the most populous outside of China) and fourth-most populous capital city. It is the leading economic, political, and cultural center of the DRC, housing several industries including manufacturing, telecommunications, banking, and entertainment. The city also hosts some of the DRC's significant institutional buildings, such as the People's Palace, Palace of the Nation, Constitutional Court, Court of Cassation, Council of State, African Union City, Marble Palace, Government House, Kinshasa Financial Center, and other national departments and agencies. The Kinshasa site has been inhabited by Teke and Humbu people for centuries and was known as Nshasa before transforming into a commercial hub during the 19th and 20th...

• Uganda - Country in East Africa

  Uganda, officially the Republic of Uganda, is a landlocked country in East-Central Africa. It is bordered to the east by Kenya, to the north by South Sudan, to the west by the Democratic Republic of the Congo, to the south-west by Rwanda, and to the south

• Tedros Adhanom Ghebreyesus - Director general of the World Health Organization

  Tedros Adhanom Ghebreyesus is an Ethiopian biologist, public health researcher, and official who has been Director-General of the World Health Organization since 2017. Tedros is the first African in the role, and was endorsed by the African Union. He play

• Bunia - Bunia is a city in the Democratic Republic of Congo. It is the capital of the province of Ituri.

  Bunia is the capital city of Ituri Province in the Democratic Republic of the Congo (DRC). It was part of the Orientale Province until that province's dissolution. It lies at an elevation of 1,275 metres or 4,180 feet on a plateau about 30 kilometres or 19 miles west of Lake Albert in the Albertine Rift, and about 25 kilometres or 16 miles east of the Ituri Rainforest. The city is at the center of the Ituri conflict between the Lendu and Hema. In the Second Congo War the city and district were the scene of much fighting and many civilian deaths from this conflict, and related clashes between militias and Uganda-based forces. Consequently, the city is the base of one of the largest United Nations peace-keeping forces in Africa, and its headquarters in northeastern DRC. The area's natural resources include gold mines over which militias and foreign forces have been fighting.

• University of Oxford - University in Oxford, England

  The University of Oxford is a collegiate research university in Oxford, England. There is evidence of teaching as early as 1096, making it the oldest university in the English-speaking world and the world's second-oldest university in continuous operation

• Africa Centres for Disease Control and Prevention - Public agency

  The Africa Centres for Disease Control and Prevention is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats.

• Ebola hemorrhagic fever - Human disease

  Ebola, also known as Ebola virus disease (EVD) and Ebola hemorrhagic fever (EHF), is a zoonotic viral hemorrhagic fever in humans and other primates, caused by four of the six known ebolaviruses. Symptoms typically start anywhere between two days and three weeks after infection. The first symptoms are usually fever, sore throat, muscle pain, and headaches. These are usually followed by vomiting, diarrhoea, rash, hepatic and renal dysfunction, at which point some people begin to bleed both internally and externally. Outbreaks of the disease have had a mortality rate of between 25 and 90%, averaging out at approximately 50%. The viral species involved and timing of treatment play a critical role in its prognosis. Death is often due to shock from fluid loss, and typically occurs between 6 and 16 days after the first symptoms appear. The viruses have caused intermittent outbreaks in sub-Saharan Africa since 1976 when the disease was first reported, with the largest one being the 2013–16 Western African epidemic. They spread through direct contact with body fluids, such as blood from infected humans or other animals, or from contact with items that have recently been contaminated with infected...

• Gilead Sciences - Biotechnology company

  Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs.

• Kisangani - City in the Democratic Republic of the Congo

  Kisangani is the capital of Tshopo province in the Democratic Republic of the Congo. It is the fifth most populous urban area in the country, with an estimated population of 1,261,000 in 2020, and the largest of the cities that lie in the tropical woodlan

• North Kivu - Province of the Democratic Republic of the Congo

  North Kivu (Swahili: Jimbo la Kivu Kaskazini) is a province bordering Lake Kivu in the eastern Democratic Republic of the Congo. The capital city is Goma. Spanning approximately 59,483 square kilometers with a population estimate of 8,985,711 as of 2020, it is bordered by Ituri to the north, Tshopo to the northwest, Maniema to the southwest, and South Kivu to the south, as well as Uganda and Rwanda to the east. North Kivu's administrative history traces back to the colonial era when it was initially part of the Stanley Falls District within the Congo Free State. Following a series of territorial reorganizations, North Kivu became incorporated into Orientale Province, with Stanleyville (modern-day Kisangani) as the provincial capital. The area gained provincial status in 1962 but was demoted to a district under Mobutu Sese Seko's regime in 1965. It was formally reinstated in 1988 under Ordinance-Law No. 88/1976 and Ordinance-Law No. 88-031, which redefined the previous Kivu Province into tripartite separate provinces: North Kivu, South Kivu, and Maniema. Presently, North Kivu comprises three cities—Goma, Butembo, and Beni—and six territories: Beni, Lubero, Masisi, Rutshuru, Nyiragongo...

• United States - Country in North America

  The United States of America, commonly known as the United States or America, is a country mostly located in central North America, between Canada and Mexico.

• Republic of the Congo - Country in Central Africa

  The Republic of the Congo, also known as Congo-Brazzaville, the Congo Republic or simply the Congo, is a country located in the western coast of Central Africa.

• Associated Press - News agency company

  The Associated Press is an American not-for-profit news agency headquartered in New York City. Founded in 1846, it operates as a cooperative, unincorporated association. Its members are U.S. newspapers and broadcasters.

• South Kivu - Province of the Democratic Republic of the Congo

  South Kivu (Swahili: Jimbo la Kivu Kusini; French: Sud-Kivu) is one of 26 provinces of the Democratic Republic of the Congo. Its capital is Bukavu. Located within the East African Rift's western branch Albertine Rift, it is bordered to the east by Lake...

• Bundibugyo - Town in Uganda

  Bundibugyo is a town in the Western Region of Uganda. It is the chief town of Bundibugyo District and the district headquarters are located there.

• Geneva - City in Switzerland

  Geneva is the second-most populous city in Switzerland and the most populous city of Romandy, the French-speaking part of Switzerland. Situated where the Rhône exits Lake Geneva, it is the capital of the Republic and Canton of Geneva. The municipality ha

• France - Country in Europe

  France, officially the French Republic, is a country consisting of metropolitan France in Western Europe and several overseas regions and territories.

• Mungwalu - Town in the Democratic Republic of the Congo

  Mongbwalu is a small town in the Djugu Territory of the Ituri Province in the Democratic Republic of the Congo.